国际肝病采访成军教授

Q1：Professor Chen， chronic HBV infection is the most important cause for the development to liver cancer. Can you share some data about that vaccine could reduce the morbidity of HCC? 
成军教授，在我国，慢性乙型肝炎病毒感染是肝癌发生的重要原因。您能否与我们分享一些注射乙肝疫苗能够减少肝癌发生的资料？

Q2：As for the patients with HBV infection， what measures should be taken to prevent the occurrence of HCC?
对于慢性乙型肝炎患者而言，预防肝癌发生的措施有哪些？

Q3：Which people are at high risk of developing HCC and need to closely monitor?
哪些患者是肝癌的高危人群，需要加强肝癌监测？

Q4：In patients with HCV or HBV infection， which factors could predict the possibility to develop HCC?
在感染HCV或HBV的患者中，哪些因素对于肝癌的发生具有预测作用？

Q5：It is known that antiviral therapy is very important for preventing HCC. For those who have not complete response to the treatment， what should we do to prevent the occurrence of HCC?
我们知道抗病毒治疗对于预防HCC非常重要，对于那些没有产生完全应答的患者，应采取什么措施预防肝癌的发生？